Titre:
  • Cost effectiveness of paclitaxel/cisplatin compared with cyclophosphamide/cisplatin in the treatment of advanced ovarian cancer in Belgium.
Auteur:Neymark, Niels; Gorlia, Thierry; Adriaenssen, Ines; Baron, Benoît; Piccart-Gebhart, Martine
Informations sur la publication:PharmacoEconomics, 20, 7, page (485-497)
Statut de publication:Publié, 2002
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Antineoplastic Combined Chemotherapy Protocols -- economics
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Cisplatin -- administration & dosage
Cost-Benefit Analysis
Cyclophosphamide -- administration & dosage
Female
Health Care Costs
Humans
Ovarian Neoplasms -- drug therapy
Ovarian Neoplasms -- mortality
Paclitaxel -- administration & dosage
Note générale:Clinical Trial
Comparative Study
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:1170-7690
info:pii/200706
info:pmid/12093304